Heraeus Medical Announces PALACOS^® Bone Cement is Now Available Direct in the United States

YARDLEY, PENNSYLVANIA - January 15, 2018 - Heraeus Medical is pleased to announce that on January 3, 2018, the company began selling the PALACOS^® portfolio of bone cement products direct through its affiliate Heraeus Medical LLC in the United States. Heraeus is the inventor and exclusive manufacturer of PALACOS^® bone cement products.

Known as a global leader in joint fixation and infection management, the company will now be able to provide its customers with earlier access to its latest innovations by selling to them directly. The company has a long history of dedication to the research and development of new bone cement offerings. PALACOS^® has been used in over 30 million cases and is recognized as a leading product by orthopedic surgeons worldwide. PALACOS^®, formerly sold exclusively through a distributor in the US, is now available directly through Heraeus Medical.

“The company is extremely excited about the opportunity to support total joint surgeons directly in the US in providing consistent, predictable outcomes with the potential for lower revision rates,” said Dr. Andrew Williamson, Heraeus Medical Board Member. Devin Childers, Vice President and General Manager of Heraeus Medical LLC, added, “The expertise and knowledge Heraeus Medical can directly offer its loyal PALACOS^® users in the US creates an atmosphere of both continued innovation and collaboration.”

Existing PALACOS^® and new customers will be able to order easily from Heraeus Medical in the US by calling 1.833.PALACOS (725-2267). Heraeus Medical has successfully sold and supported PALACOS^® direct in Europe, Australia, and several other countries through an integrated ordering process that is now available to US customers.

For more information or to order PALACOS^® in the United States, please visit www.heraeus-medical-usa.com or call 1.833.PALACOS (725-2267).